In this upbeat interview, CEO Sara Barrington of Verici DX – a next generation medical diagnostics firm focusing on the global kidney transplant market - takes me through:
00:00 Progress on #VRCI’s commercialisation strategy following July’s £6.35m fund raise and Monday’s in line H1’25 results.
11:20 Future Tutivia volumes and #VRCI breakeven sales level
14:50 Update on Thermo Fisher Scientific relationship (re pre-graft Clarava/PTRA test)
19:15 Other products/services and closing remarks
